Skip to main content
Figure 1 | Journal of Ovarian Research

Figure 1

From: A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis

Figure 1

Tumor necrosis factor alpha (TNFα) concentrations in follicular fluids. Twenty-three infertile women with Stage III or IV endometriosis were recruited for this study. Eleven patients received three courses of GnRHa (1.8 mg s.c. every 28 days), followed by a standard controlled ovarian hyperstimulation (COH) for IVF-ET (ultralong group). Twelve patients received a standard COH with mid-luteal phase GnRHa down-regulation (control group). TNFα concentrations were measured in the follicular fluid obtained at the time of oocyte retrieval. Values are mean ± SD. Statistical analysis was employed with the Mann–Whitney U-test using the Bonferroni correction.

Back to article page